Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

ClinicalTrials.gov ID: NCT00501293

Public ClinicalTrials.gov record NCT00501293. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 12:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase IIIb, Long-Term, Open-Label, Multi-Center, Extension Study Designed to Evaluate the Safety and Efficacy of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the long-term, safety of Methylphenidate Transdermal System (MTS) in aged 13-17 years diagnosed withADHD

Study identification

NCT ID
NCT00501293
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Noven Therapeutics
Industry
Enrollment
163 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
13 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Feb 2009 (Actual)
Completion
Feb 2009 (Actual)
Last update posted
Apr 26, 2017

2007 – 2009

United States locations

U.S. sites
32
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
Melmed Center Scottsdale Arizona — —
Bay Area Research Institute Lafayette California — —
Elite Clinical Trials Inc. Wildomar California — —
Sarkis Clinical Trials Gainsville Florida — —
Miami Research Associates South Miami Florida — —
Northwest Behavioral Research Ctr Roswell Georgia — —
Mountain West Clinical Trials, LLC Eagle Idaho — —
Vince and Associates Clinical Research Overland Park Kansas — —
Shire Clinical Research Site Lexington Kentucky — —
Four Rivers Clinical Research, Inc. Paducah Kentucky — —
Rochester Center for Behavioral Medicine Rochester Hills Michigan — —
Clinical Neurophysiology Services, PC Troy Michigan — —
CRI Worldwide Clementon New Jersey — —
Triangle Neuropsychiatry Durham North Carolina — —
Dakota Clinic/Innovis Health Fargo North Dakota — —
Odyssey Research Minot North Dakota — —
University Hospitals Case Medical Center Cleveland Ohio — —
Oregon center for Clinical Investigations, Inc. Eugene Oregon — —
OCCI, Inc Portland Oregon — —
Shire Clinical Research Site Media Pennsylvania — —
CRI Worldwide Philadelphia Pennsylvania — —
Rhode Island Hospital Providence Rhode Island — —
CNS Healthcare Memphis Tennessee — —
FutureSearch Trials Austin Texas — —
Claghorn-Lesem Research, Ltd. Bellaire Texas — —
Westex Clinical Investigations Lubbock Texas — —
Cerebral Research, LLC San Antonio Texas — —
Vermont Clinical Study Center Burlington Vermont — —
NeuroScience, Inc. Herndon Virginia — —
Adolescent Health Center Midlothian Virginia — —
Northwest Clinical Research Center Friday Harbor Washington — —
Eastside Therapeutic Resource Kirkland Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00501293, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 26, 2017 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00501293 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →